Global methylation correlates with clinical status in multiple sclerosis patients in the first year of IFNbeta treatment

by María Jesús Pinto-Medel, Begoña Oliver-Martos, Patricia Urbaneja-Romero, Isaac Hurtado-Guerrero, Jesús Ortega-Pinazo, Pedro Serrano-Castro, Óscar Fernández, Laura Leyva
Published 2017-08-01

Activation of the JAK-STAT Signaling Pathway after In Vitro Stimulation with IFNß in Multiple Sclerosis Patients According to the Therapeutic Response to IFNß.

by Isaac Hurtado-Guerrero, Maria Jesús Pinto-Medel, Patricia Urbaneja, Jose Luis Rodriguez-Bada, Antonio León, Miguel Guerrero, Óscar Fernández, Laura Leyva, Begoña Oliver-Martos
Published 2017-01-01

Skin Phototype Could Be a Risk Factor for Multiple Sclerosis

by Patricia Urbaneja, Isaac Hurtado-Guerrero, Miguel Ángel Hernández, Begoña Oliver-Martos, Celia Oreja-Guevara, Jesús Ortega-Pinazo, Ana Alonso, Francisco J Barón-López, Laura Leyva, Óscar Fernández, María Jesús Pinto-Medel
Published 2020-07-01

Candidate gene study of TRAIL and TRAIL receptors: association with response to interferon beta therapy in multiple sclerosis patients.

by Carlos López-Gómez, Almudena Pino-Ángeles, Teresa Órpez-Zafra, María Jesús Pinto-Medel, Begoña Oliver-Martos, Jesús Ortega-Pinazo, Carlos Arnáiz, Cristina Guijarro-Castro, Jezabel Varadé, Roberto Álvarez-Lafuente, Elena Urcelay, Francisca Sánchez-Jiménez, Óscar Fernández, Laura Leyva
Published 2013-01-01

TRAIL/TRAIL receptor system and susceptibility to multiple sclerosis.

by Carlos López-Gómez, Oscar Fernández, Juan Antonio García-León, María Jesús Pinto-Medel, Begoña Oliver-Martos, Jesús Ortega-Pinazo, Margarita Suardíaz, Lucía García-Trujillo, Cristina Guijarro-Castro, Julián Benito-León, Isidro Prat, Jezabel Varadé, Roberto Álvarez-Lafuente, Elena Urcelay, Laura Leyva
Published 2011-01-01